We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -2.71604938272 | 4.05 | 4.44 | 3.67 | 54931 | 3.83053398 | CS |
| 4 | 0.35 | 9.74930362117 | 3.59 | 4.44 | 3.4 | 94271 | 3.92133106 | CS |
| 12 | -0.64 | -13.9737991266 | 4.58 | 5.04 | 2.6 | 114750 | 3.71807728 | CS |
| 26 | -2.265 | -36.5028203062 | 6.205 | 6.81 | 2.6 | 144289 | 4.52693016 | CS |
| 52 | 0.12 | 3.14136125654 | 3.82 | 7.77 | 2.6 | 180406 | 4.93516467 | CS |
| 156 | -10.42 | -72.5626740947 | 14.36 | 26.3 | 1.94 | 344407 | 6.26030795 | CS |
| 260 | -24.06 | -85.9285714286 | 28 | 50 | 1.94 | 289186 | 8.22522052 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
